
Our Expertise
Our exceptional trial execution has made PCR a preferred partner for leading pharmaceutical companies.
In-House Capabilities
- We’re driven to advance breakthrough therapies for challenging diseases like Liver Disease/MASH, Alzheimer’s and Obesity.
- With state-of-the-art facilities and a highly specialized team, we execute complex protocols with precision.
- Our commitment to operational excellence and proactive communication ensures sponsors stay informed, aligned, and confident at every stage.

Advanced Imaging Infrastructure
Access to MRI, DXA, and amyloid/tau PET imaging to support CNS and metabolic endpoints with precision.
Dedicated Infusion Suites
On-site infusion rooms optimized for complex administration protocols.
Early-Phase Trial Readiness
Phase 1 facility equipped for overnight stays, and safety monitoring.
Mobile Diagnostic Technology
Portable FibroScan units enable flexible liver assessments at both clinical and outreach locations.
Protocol Design & Execution Expertise
In-house experts collaborate with sponsors to optimize study design, recruitment feasibility, and operational planning.
On-Staff Certified Clinical Raters
Credentialed raters, including CDR-certified staff, ensure consistency and reliability in cognitive assessments.
Physician Leadership & Mentorship
Experienced principal investigators offer hands-on mentoring and oversight to ensure trial integrity and protocol adherence.
Multidisciplinary Clinical Team
Physicians, coordinators, and support staff trained across CNS, metabolic, and liver specialties for seamless execution of complex trials.

SLD
Top Global Enroller in MASH/MASLD Trials
Proven track record of exceeding enrollment targets in complex steatotic liver disease studies across diverse populations.
Liver-Focused Clinical Infrastructure
Dedicated hepatology-trained investigators; on-site FibroScan and in-house quantitative liver MRI with PDFF, MRE, and cT1 partnerships; and disease-specific workflows.
Board-certified hepatologists and liver-trained investigator team
Pre-screened, treatment-naive patient databases
On-site FibroScan and in-house quantitative liver MRI with PDFF, MRE, and cT1
In-house regulatory and quality assurance teams
Multi-site geographic coverage with diverse patient reach
Bilingual staff and patient engagement teams
Community outreach and education programs
Flexible scheduling and telehealth visit capable
High enrollment velocity and retention performance tracking
CNS
High-Performer in Alzheimer’s Disease Trials
Proven success in enrolling and retaining participants across mild cognitive impairment (MCI), Alzheimer’s disease, and related dementia trials.
Dedicated Cognitive Assessment & Diagnostic Capabilities
In-house neurocognitive testing, memory screening programs, and access to specialty and geriatric-trained clinicians.
Fast Recruitment from Engaged At-Risk Populations
Robust patient registries, community outreach, and partnerships with primary care, memory clinics, and senior organizations drive fast enrollment.

On-site cognitive testing and memory screening
Experienced PI’s with more than 50 years of combined leadership across Neurology, Geriatrics, and Psychiatry
Access to MCI, early AD, and moderate dementia populations
Pre-screened participant registries with family/caregiver contacts
Partnerships with primary care and memory care clinics
Culturally sensitive outreach and bilingual staff
Dedicated caregiver education and retention programs
Rater training programs across all PCR sites with shared best practices
Integration of AI to support efficiency and accuracy for recruitment

Cardiometabolic Disorders
Deep Access to High-Risk, Diverse Populations
Sites located in areas with elevated prevalence of cardiometabolic risk, offering access to treatment-naive and comorbid patients.
Streamlined Recruitment & Pre-Screening Workflows
Active participant registries, physician referrals, and EMR integration support rapid patient identification and qualification.
Integrated Multidisciplinary Clinical Oversight
Investigators with backgrounds in endocrinology, cardiology, hepatology, and internal medicine ensure comprehensive management of complex comorbidities.
Large patient databases across type 2 diabetes, obesity, hypertension, and dyslipidemia
Multi-site coverage in high-prevalence, underserved regions
Board-certified physicians
Pre-screening protocols integrated with EHR and community health data
In-house lab capabilities and real-time lab data tracking
On-site diagnostics: blood pressure, ECG, glucose monitoring, BMI, etc.
High-performing recruitment from both clinical and community channels
Strong retention through bilingual support, education, and lifestyle coaching
Obesity
Access to Highly Motivated Weight-Management Populations
Sites located in communities with strong interest in new obesity treatments and active engagement in weight-loss programs, enabling rapid identification of eligible participants.
Purpose-Built Workflows for BMI-Driven Studies
Customized screening pathways, protocol-specific BMI stratification, and automated eligibility tools streamline qualification and reduce screen failure rates.
Clinical Oversight for Complex Obesity Care
Investigators with expertise in weight-management medicine provide coordinated oversight that considers behavioral, metabolic, and lifestyle factors throughout the study.

